SCHEMBL5797653

SCHEMBL5797653

Cc1c(CC(=O)O)c2cc(O)ccc2n1C(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 6/20 0.74
PTGS2 P35354 6/20 0.74
AKR1C3 P42330 4/20 0.57
AKR1C2 P52895 4/20 0.57
ABCB1 P08183 3/20 0.55
HIF1A Q16665 3/20 0.55
GLO1 Q04760 2/20 0.55
LMNA P02545 2/20 0.55
CYP1A2 P05177 2/20 0.55
CYP2D6 P10635 2/20 0.55
CYP2C9 P11712 2/20 0.55
NPSR1 Q6W5P4 2/20 0.55
KDM4E B2RXH2 1/20 0.55
MEN1 O00255 1/20 0.55
PTGES O14684 1/20 0.55
ABCC3 O15438 1/20 0.55
ABCC4 O15439 1/20 0.55
ABCB11 O95342 1/20 0.55
MT-CO2 P00403 1/20 0.55
ALB P02768 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL6025717 0.98 PTGS1 (0.71) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL4209798 0.86 ABCB1 (0.71) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2996680 0.85 PTGS1 (1.00) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL6024947 0.83 PTGS1 (0.66) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL5560443 0.82 PTGS1 (0.78) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2002967 0.81 PTGS1 (0.79) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL2465162 0.79 PTGS1 (0.80) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL5554419 0.78 PTGS1 (0.74) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL5814525 0.78 PTGS1 (0.71) PTGS1PTGS2AKR1C3AKR1C2ABCB1
SCHEMBL4055730 0.78 PTGS1 (0.82) PTGS1PTGS2AKR1C3AKR1C2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1628532-A2 METHODS FOR THE PROTECTION OF MEMORY AND COGNITION Microbia, Inc. (US) 2006-03-01 EP claimed
US-20050004104-A1 Methods for the protection of memory and cognition IRONWOOD PHARMACEUTICALS, INC. 2005-01-06 US claimed
WO-2004108085-A2 METHODS FOR THE PROTECTION OF MEMORY AND COGNITION MICROBIA, INC. (US) 2004-12-16 WO claimed
WO-2006050120-A2 SYNTHESIS OF COX-2 AND FAAH INHIBITORS MICROBIA, INC. (US) 2006-05-11 WO disclosed
EP-1628532-A2 METHODS FOR THE PROTECTION OF MEMORY AND COGNITION Microbia, Inc. (US) 2006-03-01 EP disclosed
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors IRONWOOD PHARMACEUTICALS, INC. 2005-10-20 US disclosed
US-20050004104-A1 Methods for the protection of memory and cognition IRONWOOD PHARMACEUTICALS, INC. 2005-01-06 US disclosed
WO-2004108085-A2 METHODS FOR THE PROTECTION OF MEMORY AND COGNITION MICROBIA, INC. (US) 2004-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004104-A1 Methods for the protection of memory and cognition PTGES2, PTGS2, PTGS1 PTGS1 3/4885PTGS2 2/4885AKR1C3 2613/4885
US-20050234244-A1 Synthesis of COX-2 and FAAH inhibitors FAAH2, FAAH, PTGES2 PTGS1 7/4885PTGS2 4/4885AKR1C3 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.